Chen Chen
Stock Analyst at UBS
(4.58)
# 983
Out of 5,125 analysts
47
Total ratings
58.6%
Success rate
38.6%
Average return
Main Sectors:
Stocks Rated by Chen Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $149.00 | $89.10 | +67.23% | 9 | Sep 29, 2026 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $51.10 → $62.00 | $49.62 | +24.95% | 5 | Sep 1, 2026 | |
| HKG: 3759 Pharmaron Beijing Co., Ltd. | Downgraded: Hold | $35.30 | $30.06 | +17.43% | 1 | Aug 25, 2026 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Reiterated: Hold | $34.70 | $15.94 | +117.69% | 4 | Mar 13, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Reiterated: Buy | $23.60 | $12.05 | +95.85% | 5 | Dec 14, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Hold | $63.80 | $70.90 | -10.01% | 6 | Dec 9, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Reiterated: Buy | $50.00 → $56.30 | $38.94 | n/a | 4 | Sep 1, 2025 | |
| HKG: 6127 Joinn Laboratories(China)Co.,Ltd. | Reiterated: Hold | $14.30 → $16.30 | $24.18 | n/a | 5 | Jul 14, 2025 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Upgraded: Buy | $40.10 → $70.40 | $200.40 | n/a | 2 | Nov 1, 2024 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Reiterated: Buy | $20.00 → $9.50 | $21.18 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35.70 | $24.28 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $286 | $424.44 | n/a | 1 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $123.10 | $463.80 | n/a | 1 | Nov 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 220p | 637p | n/a | 1 | Aug 30, 2021 |
Akeso, Inc.
Sep 29, 2026
Reiterated: Buy
Price Target: $149.00
Current: $89.10
Upside: +67.23%
WuXi Biologics (Cayman) Inc.
Sep 1, 2026
Reiterated: Buy
Price Target: $51.10 → $62.00
Current: $49.62
Upside: +24.95%
Pharmaron Beijing Co., Ltd.
Aug 25, 2026
Downgraded: Hold
Price Target: $35.30
Current: $30.06
Upside: +17.43%
Shanghai Junshi Biosciences Co., Ltd.
Mar 13, 2026
Reiterated: Hold
Price Target: $34.70
Current: $15.94
Upside: +117.69%
InnoCare Pharma Limited
Dec 14, 2025
Reiterated: Buy
Price Target: $23.60
Current: $12.05
Upside: +95.85%
RemeGen Co., Ltd.
Dec 9, 2025
Reiterated: Hold
Price Target: $63.80
Current: $70.90
Upside: -10.01%
Hangzhou Tigermed Consulting Co., Ltd
Sep 1, 2025
Reiterated: Buy
Price Target: $50.00 → $56.30
Current: $38.94
Upside: n/a
Joinn Laboratories(China)Co.,Ltd.
Jul 14, 2025
Reiterated: Hold
Price Target: $14.30 → $16.30
Current: $24.18
Upside: n/a
WuXi AppTec Co., Ltd.
Nov 1, 2024
Upgraded: Buy
Price Target: $40.10 → $70.40
Current: $200.40
Upside: n/a
Shanghai MicroPort MedBot (Group) Co., Ltd.
Sep 11, 2024
Reiterated: Buy
Price Target: $20.00 → $9.50
Current: $21.18
Upside: n/a
Apr 23, 2024
Initiated Coverage: Buy
Price Target: $35.70
Current: $24.28
Upside: n/a
Feb 29, 2024
Reiterated: Buy
Price Target: $286
Current: $424.44
Upside: n/a
Nov 23, 2023
Initiated Coverage: Buy
Price Target: $123.10
Current: $463.80
Upside: n/a
Aug 30, 2021
Reiterated: Hold
Price Target: 220p
Current: 637p
Upside: n/a